We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Innovative Technology Integrates Laser Optics with Ultrasound to Enhance Breast Cancer Diagnosis

By MedImaging International staff writers
Posted on 19 Jan 2024
Print article
Image: The newest version of the Imagio breast imaging system has received FDA approval (Photo courtesy of Seno Medical)
Image: The newest version of the Imagio breast imaging system has received FDA approval (Photo courtesy of Seno Medical)

Mammograms are an essential part of preventive healthcare, and when an initial review reveals a suspicious lesion, additional imaging and/or invasive breast biopsies could be the next step in diagnosis. However, breast biopsy procedures caused by false-positive assessments can be costly for healthcare systems and cause millions of women unnecessary stress and anxiety. Now, a cutting-edge technology offers highly differentiated opto-acoustic/ultrasound (OA/US) exams to diagnose breast cancer and significantly reduce unnecessary breast biopsies.

Seno Medical’s (San Antonio, TX, USA) innovative OA/US technology has revolutionized the breast cancer imaging sector by integrating laser optics with ultrasound for enhanced cancer diagnosis. The company’s Imagio Breast Imaging System, which was ranted Pre-Market Approval (PMA) by the US Food and Drug Administration (FDA) in 2021, seamlessly combines opto-acoustics and ultrasound to provide real-time results to clinicians. In comparison to traditional breast cancer diagnosis technologies, Seno Medical's solution is more effective and patient-friendly as it provides clinicians with functional information about the oxygenation and deoxygenation in and around a suspicious mass in order to better determine the possible malignancy earlier during the care pathway and non-invasively.

Seno Medical's technology also uses the body's hemoglobin as a natural contrast agent, enhancing its safety and accuracy. This system significantly boosts clinicians' confidence in distinguishing malignant and benign breast masses, thus reducing biopsies and exams and improving patient care. Seno Medical's advanced breast cancer diagnosis technology can resolve serious industry challenges like staff shortages and high rate of unnecessary biopsies. The company is now collaborating with experts in artificial intelligence (AI) and deep learning to refine its diagnostic capabilities in the next few years. Frost & Sullivan recently recognized Seno Medical with the 2023 US Enabling Technology Leadership Award.

"Seno Medical's opto-acoustic technology for breast imaging is non-invasive, has no ionizing radiation, does not use contrast agents or radionuclides, and does not require the compression that is used in mammography," said Sudhakar Mishra, senior director of growth advisory for health and life sciences at Frost & Sullivan.

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound System
P20 Elite
Oncology Information System
RayCare
Thyroid Shield
Standard Thyroid Shield

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.